Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 573

1.

Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.

Begué C, Martinetto H, Schultz M, Rojas E, Romero C, D'Giano C, Sevlever G, Somoza M, Taratuto AL.

Neuroepidemiology. 2011;37(3-4):193-202. doi: 10.1159/000331907. Epub 2011 Nov 5.

PMID:
22067221
2.

Creutzfeldt-Jakob disease in Austria: an autopsy-controlled study.

Gelpi E, Heinzl H, Hoftberger R, Unterberger U, Strobel T, Voigtlander T, Drobna E, Jarius C, Lang S, Waldhor T, Bernheimer H, Budka H.

Neuroepidemiology. 2008;30(4):215-21. doi: 10.1159/000126915. Epub 2008 Apr 18.

PMID:
18424902
3.

Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease.

Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA.

Ann Neurol. 2004 Nov;56(5):702-8.

PMID:
15449324
4.

Surveillance for Creutzfeldt-Jakob disease in China from 2006 to 2007.

Shi Q, Gao C, Zhou W, Zhang BY, Chen JM, Tian C, Jiang HY, Han J, Xiang NJ, Wang XF, Gao YJ, Dong XP.

BMC Public Health. 2008 Oct 18;8:360. doi: 10.1186/1471-2458-8-360.

5.

Description and analysis of 12 years of surveillance for Creutzfeldt-Jakob disease in Denmark, 1997 to 2008.

Gubbels S, Bacci S, Laursen H, Hogenhaven H, Cowan S, Molbak K, Christiansen M.

Euro Surveill. 2012 Apr 12;17(15). pii: 20142.

6.

[Eleven years of autopsy on account of Creutzfeldt-Jakob disease in the Netherlands].

Jansen C, Schuur M, Spliet WG, van Gool WA, van Duijn CM, Rozemuller AJ.

Ned Tijdschr Geneeskd. 2009;153:A172. Dutch.

PMID:
19785859
7.

Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance.

Heinemann U, Krasnianski A, Meissner B, Varges D, Kallenberg K, Schulz-Schaeffer WJ, Steinhoff BJ, Grasbon-Frodl EM, Kretzschmar HA, Zerr I.

Brain. 2007 May;130(Pt 5):1350-9.

PMID:
17472986
8.

Novel prion protein gene mutation in an octogenarian with Creutzfeldt-Jakob disease.

Collins S, Boyd A, Fletcher A, Byron K, Harper C, McLean CA, Masters CL.

Arch Neurol. 2000 Jul;57(7):1058-63.

PMID:
10891990
9.

[Epidemiological surveillance of Creutzfeldt-Jakob in France].

Brandel JP, Salomon D, Capek I, Vaillant V, Alpérovitch A.

Rev Neurol (Paris). 2009 Aug-Sep;165(8-9):684-93. doi: 10.1016/j.neurol.2009.04.006. Epub 2009 May 20. Review. French.

PMID:
19467685
10.

[Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].

Zaborowski A.

Psychiatr Pol. 2004 Mar-Apr;38(2):297-309. Review. Polish.

PMID:
15307294
11.

[Psychiatric manifestations of a new variant of Creutzfeldt-Jakob disease. Apropos of a case].

Dervaux A, Vicart S, Lopes F, Le Borgne MH.

Encephale. 2001 Mar-Apr;27(2):194-7. French.

PMID:
11407273
12.

Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates.

Brandel JP, Delasnerie-Lauprêtre N, Laplanche JL, Hauw JJ, Alpérovitch A.

Neurology. 2000 Mar 14;54(5):1095-9.

PMID:
10720280
13.

Creutzfeldt-Jakob disease: diagnostic utility of 14-3-3 protein immunodetection in cerebrospinal fluid.

Collins S, Boyd A, Fletcher A, Gonzales M, McLean CA, Byron K, Masters CL.

J Clin Neurosci. 2000 May;7(3):203-8.

PMID:
10833616
14.

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S.

Neurology. 2002 Jan 22;58(2):192-7.

PMID:
11805244
15.

Prospective 10-year surveillance of human prion diseases in Japan.

Nozaki I, Hamaguchi T, Sanjo N, Noguchi-Shinohara M, Sakai K, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Moriwaka F, Shiga Y, Kuroiwa Y, Nishizawa M, Kuzuhara S, Inuzuka T, Takeda M, Kuroda S, Abe K, Murai H, Murayama S, Tateishi J, Takumi I, Shirabe S, Harada M, Sadakane A, Yamada M.

Brain. 2010 Oct;133(10):3043-57. doi: 10.1093/brain/awq216. Epub 2010 Sep 20.

PMID:
20855418
16.

14-3-3 protein in the CSF of patients with rapidly progressive dementia.

Huang N, Marie SK, Livramento JA, Chammas R, Nitrini R.

Neurology. 2003 Aug 12;61(3):354-7.

PMID:
12913197
17.

The Heidenhain variant of Creutzfeldt-Jakob disease.

Kropp S, Schulz-Schaeffer WJ, Finkenstaedt M, Riedemann C, Windl O, Steinhoff BJ, Zerr I, Kretzschmar HA, Poser S.

Arch Neurol. 1999 Jan;56(1):55-61.

PMID:
9923761
18.

Association of cerebrospinal fluid prion protein levels and the distinction between Alzheimer disease and Creutzfeldt-Jakob disease.

Dorey A, Tholance Y, Vighetto A, Perret-Liaudet A, Lachman I, Krolak-Salmon P, Wagner U, Struyfs H, De Deyn PP, El-Moualij B, Zorzi W, Meyronet D, Streichenberger N, Engelborghs S, Kovacs GG, Quadrio I.

JAMA Neurol. 2015 Mar;72(3):267-75. doi: 10.1001/jamaneurol.2014.4068.

PMID:
25559883
19.

[Diagnostic usefulness of the determination of protein 14-3-3 in cerebrospinal fluid in Creutzfeld-Jakob disease].

Sáiz A, Marín C, Tolosa E, Graus F.

Neurologia. 1998 Aug-Sep;13(7):324-8. Spanish.

PMID:
9810794
20.

Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease.

Zerr I, Bodemer M, Gefeller O, Otto M, Poser S, Wiltfang J, Windl O, Kretzschmar HA, Weber T.

Ann Neurol. 1998 Jan;43(1):32-40.

PMID:
9450766

Supplemental Content

Support Center